TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF AFRICA BIOANALYTICAL TESTING SERVICES MARKET 11
1.4 LIMITATIONS 12
1.5 MARKETS COVERED 13
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 GEOGRAPHICAL SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
2.6 MULTIVARIATE MODELLING 19
2.7 TYPE LIFELINE CURVE 19
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.9 DBMR MARKET POSITION GRID 21
2.10 MARKET END USER COVERAGE GRID 22
2.11 VENDOR SHARE ANALYSIS 23
2.12 SECONDARY SOURCES 24
2.13 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 27
4.1 PORTER'S FIVE FORCES 28
4.2 PESTEL ANALYSIS 29
5 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: REGULATIONS 30
5.1 REGULATION IN AFRICA: 30
5.1.1 GUIDELINES FOR BIOANALYTICAL TESTING SERVICES BY SAHPRA: 30
6 MARKET OVERVIEW 32
6.1 DRIVERS 34
6.1.1 RISE IN FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSMILARS 34
6.1.2 INCREASE IN PREFERENCE FOR OUTSOURCING ANALYTICAL TESTING 34
6.1.3 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 35

6.2 RESTRAINTS 35
6.2.1 DEARTH OF SKILLED PROFESSIONALS 35
6.2.2 PRICING PRESSURE FACED BY MAJOR PLAYERS 35
6.3 OPPORTUNITIES 36
6.3.1 RISE IN ADOPTION OF THE QUALITY BY DESIGN APPROACH 36
6.3.2 RISE IN DEMAND FOR SPECIALIZED BIOANALYTICAL TESTING SERVICES 36
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 37
6.4 CHALLENGES 37
6.4.1 INNOVATIVE FORMULATIONS DEMANDING A UNIQUE BIOANALYTICAL TESTING APPROACH 37
6.4.2 GROWING NEED TO IMPROVE THE SENSITIVITY OF BIOANALYTICAL METHODS 38
7 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 39
7.1 OVERVIEW 40
7.2 BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES 42
7.2.1 PHARMACOKINETIC (PK) ANALYSIS 43
7.2.2 BIOEQUIVALENCE STUDIES 43
7.2.3 BIOAVAILABILITY STUDIES 43
7.2.4 METHOD DEVELOPMENT & VALIDATION 43
7.2.5 LEAD OPTIMIZATION STUDIES 43
7.2.6 DOSE FORMULATION ANALYSIS 44
7.2.7 BIOANALYTICAL TECHNOLOGIES 44
7.2.8 OTHERS 44
7.3 SMALL MOLECULE BIOANALYTICAL SERVICES 44
7.3.1 METHOD DEVELOPMENT & VALIDATION 45
7.3.2 METABOLITE IDENTIFYING & SCREENING 45
7.3.3 SUPPORT FOR PRE-CLINICAL ANIMAL STUDIES 45
7.3.4 DRIED BLOOD SPOT ANALYSIS 45
7.3.5 TISSUE BIOANALYSIS 45
7.3.6 HAZARDOUS SAMPLE LABORATORY FOR HIV & HEPATITIS-B 45
7.3.7 BIOMARKERS ASSAY 46
7.3.8 OTHERS 46
7.4 LARGE MOLECULE BIOANALYTICAL SERVICES 46
7.4.1 IMMUNOCHEMISTRY SERVICES 47
7.4.2 BIOMARKER ASSAYS 47
7.4.3 METABOLITE IDENTIFYING & SCREENING 47
7.4.4 QUANTITATIVE IMMUNOASSAYS 47
7.4.5 IMMUNOGENICITY ASSAYS 47
7.4.6 PHARMACOKINETICS (PK) ANALYSIS 47
7.4.7 LIGAND-BINDING ASSAYS 48
7.4.8 OTHERS 48
8 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 49
8.1 OVERVIEW 50
8.2 CLINICAL RESEARCH ORGANIZATIONS 52
8.3 ACADEMIC AND RESEARCH INSTITUTES 53
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 53
8.5 HOSPITALS LABS 54
8.6 OTHERS 54
9 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY 55
9.1 SOUTH AFRICA 60
9.2 NIGERIA 63
9.3 ETHIOPIA 66
9.4 ANGOLA 69
9.5 REST OF AFRICA 72
10 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: COMPANY LANDSCAPE 73
10.1 COMPANY SHARE ANALYSIS: AFRICA 73
11 SWOT ANALYSIS 74
12 COMPANY PROFILE 75
12.1 LABCORP 75
12.1.1 COMPANY SNAPSHOT 75
12.1.2 REVENUE ANALYSIS 75
12.1.3 PRODUCT PORTFOLIO 76
12.1.4 RECENT DEVELOPMENTS 76
12.2 FARMOVS (PTY) LTD 77
12.2.1 COMPANY SNAPSHOT 77
12.2.2 PRODUCT PORTFOLIO 77
12.2.3 RECENT DEVELOPMENTS 77
12.3 SGS SA 78
12.3.1 COMPANY SNAPSHOT 78
12.3.2 REVENUE ANALYSIS 78
12.3.3 PRODUCT PORTFOLIO 79
12.3.4 RECENT DEVELOPMENTS 79
12.4 BARC SOUTH AFRICA 80
12.4.1 COMPANY SNAPSHOT 80
12.4.2 PRODUCT PORTFOLIO 80
12.4.3 RECENT DEVELOPMENTS 80

12.5 Q2 SOLUTIONS. 81
12.5.1 COMPANY SNAPSHOT 81
12.5.2 PRODUCT PORTFOLIO 81
12.5.3 RECENT DEVELOPMENTS 81
12.6 MEDPACE 82
12.6.1 COMPANY SNAPSHOT 82
12.6.2 REVENUE ANALYSIS 82
12.6.3 PRODUCT PORTFOLIO 83
12.6.4 RECENT DEVELOPMENTS 83
12.7 MERIEUX NUTRISCIENCES CORPORATION 84
12.7.1 COMPANY SNAPSHOT 84
12.7.2 PRODUCT PORTFOLIO 84
12.7.3 RECENT DEVELOPMENTS 84
12.8 SYNEXA LIFE SCIENCES BV 85
12.8.1 COMPANY SNAPSHOT 85
12.8.2 PRODUCT PORTFOLIO 85
12.8.3 RECENT DEVELOPMENTS 86
13 QUESTIONNAIRE 87
14 RELATED REPORTS 89

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.